Journal of Antimicrobial Chemotherapy (2002) 49, 973-980
© 2002 The British Society for Antimicrobial Chemotherapy
Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms
Departments of 1Microbiology and 2Medicine, Division of Infectious Diseases, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA
Received 6 July 2001; returned 23 November 2001; revised 2 January 2002; accepted 4 March 2002.
A main characteristic associated with microbial biofilms is their increased resistance to antimicrobial chemotherapies. However, at present very little is known about the phenotypic changes that occur during the transition from the planktonic to the biofilm mode of growth. Candida albicans biofilms displayed an organized three-dimensional structure, and consisted of a dense network of yeasts and filamentous cells deeply embedded in exopolymeric matrix. These biofilms were intrinsically resistant to fluconazole. Moreover, the resistance phenotype was maintained by sessile cells when resuspended as free-floating cells, thus demonstrating that biofilm integrity and the presence of exopolymeric material are not the sole determinants of biofilm resistance. Under planktonic conditions, one of the main mechanisms of azole resistance in C. albicans is through active efflux of these drugs mediated by ATP-binding cassette (ABC) transporters and major facilitators. In this study we used northern hybridization to monitor expression of genes belonging to two different types of efflux pump, the ABC transporters and major facilitators (encoded by CDR and MDR genes, respectively), in C. albicans populations under both planktonic and biofilm growth. It was demonstrated that expression of genes encoding both types of efflux pump were up-regulated during the course of biofilm formation and development. Moreover, antifungal susceptibilities of biofilms formed by a set of C. albicans mutant strains deficient in efflux pumps were investigated to determine their contribution to biofilm resistance. Remarkably, mutants carrying single and double deletion mutations in 
cdr1, cdr2, mdr1, cdr1/cdr2 and mdr1/cdr1 were hypersusceptible to fluconazole when planktonic, but still retained the resistant phenotype during biofilm growth. These analyses demonstrate that C. albicans biofilm resistance is a complex phenomenon that cannot be explained by one mechanism alone, instead it is multifactorial and may involve different molecular mechanisms of resistance compared with those displayed by planktonic cells.
Keywords: Candida albicans, biofilm, efflux pumps, resistance
* Correspondence address. Department of Medicine, Division of Infectious Diseases, The University of Texas Health Science Center at San Antonio, South Texas Centers for Biology in Medicine, Texas Research Park, 15355 Lambda Drive, San Antonio, TX 78245, USA. Tel: +1-210-562-5017; Fax: +1-210-562-5016; E-mail: RIBOT{at}UTHSCSA.EDU
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. A. G. Ferreira, J. H. Carr, C. E. F. Starling, M. A. de Resende, and R. M. Donlan Biofilm Formation and Effect of Caspofungin on Biofilm Structure of Candida Species Bloodstream Isolates Antimicrob. Agents Chemother., October 1, 2009; 53(10): 4377 - 4384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Harriott and M. C. Noverr Candida albicans and Staphylococcus aureus Form Polymicrobial Biofilms: Effects on Antimicrobial Resistance Antimicrob. Agents Chemother., September 1, 2009; 53(9): 3914 - 3922. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Cannon, E. Lamping, A. R. Holmes, K. Niimi, P. V. Baret, M. V. Keniya, K. Tanabe, M. Niimi, A. Goffeau, and B. C. Monk Efflux-Mediated Antifungal Drug Resistance Clin. Microbiol. Rev., April 1, 2009; 22(2): 291 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G. Pierce, D. P. Thomas, and J. L. Lopez-Ribot Effect of tunicamycin on Candida albicans biofilm formation and maintenance J. Antimicrob. Chemother., March 1, 2009; 63(3): 473 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.M. ten Cate, F.M. Klis, T. Pereira-Cenci, W. Crielaard, and P.W.J. de Groot Molecular and Cellular Mechanisms That Lead to Candida Biofilm Formation Journal of Dental Research, February 1, 2009; 88(2): 105 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Nett, K. M. Guite, A. Ringeisen, K. A. Holoyda, and D. R. Andes Reduced Biocide Susceptibility in Candida albicans Biofilms Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3411 - 3413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Seneviratne, L. J. Jin, Y. H. Samaranayake, and L. P. Samaranayake Cell Density and Cell Aging as Factors Modulating Antifungal Resistance of Candida albicans Biofilms Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3259 - 3266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Al-Dhaheri and L. J. Douglas Absence of Amphotericin B-Tolerant Persister Cells in Biofilms of Some Candida Species Antimicrob. Agents Chemother., May 1, 2008; 52(5): 1884 - 1887. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Mowat, J. Butcher, S. Lang, C. Williams, and G. Ramage Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus J. Med. Microbiol., September 1, 2007; 56(9): 1205 - 1212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Perumal, S. Mekala, and W. L. Chaffin Role for Cell Density in Antifungal Drug Resistance in Candida albicans Biofilms Antimicrob. Agents Chemother., July 1, 2007; 51(7): 2454 - 2463. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Jain, R. Kohli, E. Cook, P. Gialanella, T. Chang, and B. C. Fries Biofilm Formation by and Antifungal Susceptibility of Candida Isolates from Urine Appl. Envir. Microbiol., March 15, 2007; 73(6): 1697 - 1703. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Bruzual, P. Riggle, S. Hadley, and C. A. Kumamoto Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole J. Antimicrob. Chemother., March 1, 2007; 59(3): 441 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Nett, L. Lincoln, K. Marchillo, R. Massey, K. Holoyda, B. Hoff, M. VanHandel, and D. Andes Putative Role of {beta}-1,3 Glucans in Candida albicans Biofilm Resistance Antimicrob. Agents Chemother., February 1, 2007; 51(2): 510 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. LaFleur, C. A. Kumamoto, and K. Lewis Candida albicans Biofilms Produce Antifungal-Tolerant Persister Cells Antimicrob. Agents Chemother., November 1, 2006; 50(11): 3839 - 3846. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Al-Fattani and L. J. Douglas Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J. Med. Microbiol., August 1, 2006; 55(Pt 8): 999 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.M. Coogan, P.L. Fidel Jr., M.C. Komesu, N. Maeda, and L.P. Samaranayake (B1) Candida and Mycotic Infections Advances in Dental Research, April 1, 2006; 19(1): 130 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Murillo, G. Newport, C.-Y. Lan, S. Habelitz, J. Dungan, and N. M. Agabian Genome-Wide Transcription Profiling of the Early Phase of Biofilm Formation by Candida albicans Eukaryot. Cell, September 1, 2005; 4(9): 1562 - 1573. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Richard, C. J. Nobile, V. M. Bruno, and A. P. Mitchell Candida albicans Biofilm-Defective Mutants Eukaryot. Cell, August 1, 2005; 4(8): 1493 - 1502. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Ramage, S. P. Saville, D. P. Thomas, and J. L. Lopez-Ribot Candida Biofilms: an Update Eukaryot. Cell, April 1, 2005; 4(4): 633 - 638. [Full Text] [PDF]
|
|
|
|
|
|
Y.-Y. Cao, Y.-B. Cao, Z. Xu, K. Ying, Y. Li, Y. Xie, Z.-Y. Zhu, W.-S. Chen, and Y.-Y. Jiang cDNA Microarray Analysis of Differential Gene Expression in Candida albicans Biofilm Exposed to Farnesol Antimicrob. Agents Chemother., February 1, 2005; 49(2): 584 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Andes, J. Nett, P. Oschel, R. Albrecht, K. Marchillo, and A. Pitula Development and Characterization of an In Vivo Central Venous Catheter Candida albicans Biofilm Model Infect. Immun., October 1, 2004; 72(10): 6023 - 6031. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Al-Fattani and L. J. Douglas Penetration of Candida Biofilms by Antifungal Agents Antimicrob. Agents Chemother., September 1, 2004; 48(9): 3291 - 3297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Mateus, S. A. Crow Jr., and D. G. Ahearn Adherence of Candida albicans to Silicone Induces Immediate Enhanced Tolerance to Fluconazole Antimicrob. Agents Chemother., September 1, 2004; 48(9): 3358 - 3366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Dumitru, J. M. Hornby, and K. W. Nickerson Defined Anaerobic Growth Medium for Studying Candida albicans Basic Biology and Resistance to Eight Antifungal Drugs Antimicrob. Agents Chemother., July 1, 2004; 48(7): 2350 - 2354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Garcia-Sanchez, S. Aubert, I. Iraqui, G. Janbon, J.-M. Ghigo, and C. d'Enfert Candida albicans Biofilms: a Developmental State Associated With Specific and Stable Gene Expression Patterns Eukaryot. Cell, April 1, 2004; 3(2): 536 - 545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Bachmann, G. Ramage, K. VandeWalle, T. F. Patterson, B. L. Wickes, and J. L. Lopez-Ribot Antifungal Combinations against Candida albicans Biofilms In Vitro Antimicrob. Agents Chemother., November 1, 2003; 47(11): 3657 - 3659. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. Mukherjee, J. Chandra, D. M. Kuhn, and M. A. Ghannoum Mechanism of Fluconazole Resistance in Candida albicans Biofilms: Phase-Specific Role of Efflux Pumps and Membrane Sterols Infect. Immun., August 1, 2003; 71(8): 4333 - 4340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Riou, F. Guegnard, Y. Le Vern, and D. Kerboeuf Modulation of the multidrug resistance (MDR) system in the nematode Haemonchus contortus by changing cholesterol content: effects on resistance to anthelmintics J. Antimicrob. Chemother., August 1, 2003; 52(2): 180 - 187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Bachmann, K. VandeWalle, G. Ramage, T. F. Patterson, B. L. Wickes, J. R. Graybill, and J. L. Lopez-Ribot In Vitro Activity of Caspofungin against Candida albicans Biofilms Antimicrob. Agents Chemother., November 1, 2002; 46(11): 3591 - 3596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Ramage, S. P. Saville, B. L. Wickes, and J. L. Lopez-Ribot Inhibition of Candida albicans Biofilm Formation by Farnesol, a Quorum-Sensing Molecule Appl. Envir. Microbiol., November 1, 2002; 68(11): 5459 - 5463. [Abstract] [Full Text] [PDF]
|
|